Kumar Neil insider trades
Kumar Neil has filed 61 Form 4s with the SEC that we hold, for BridgeBio Pharma, Inc. (BBIO) (Chief Executive Officer, Director), BridgeBio Oncology Therapeutics, Inc. (BBOT) (Director) and Maze Therapeutics, Inc. (MAZE) (Director). Across all of them we count 0 purchases worth $0 and 158 sales worth $113.8M reported on Form 4. In the last 12 months: 0 purchases ($0) and 104 sales ($53.5M). The largest single trade was a sale of 326,932 shares of BridgeBio Pharma, Inc. worth $11.9M, dated 2025-01-28. Of 9 sales filed since we began reading the 10b5-1 checkbox, 9 (100%) were marked as made under a 10b5-1 trading plan. The first filing on our record is dated 2021-08-18 and the latest 2026-09-21.
BridgeBio Pharma, Inc. (BBIO)
Chief Executive Officer, Director · 59 filings · 158 purchases and sales
| Trade date | Code | Shares | Value as filed | Filed | Source |
|---|---|---|---|---|---|
| 2022-11-17 | S, sale reported on Form 4 | 34,640 | $325.6K | 2022-11-18 | SEC |
| 2022-12-21 | S, sale reported on Form 4 | 200,000 | - | 2022-12-21 | SEC |
| 2023-01-05 | S, sale reported on Form 4 | 120,000 | $920.4K | 2023-01-06 | SEC |
| 2023-02-03 | S, sale reported on Form 4 | 120,000 | $1.3M | 2023-02-06 | SEC |
| 2023-02-17 | S, sale reported on Form 4 | 44,798 | $568.9K | 2023-02-21 | SEC |
| 2023-03-03 | S, sale reported on Form 4 | 120,000 | $1.3M | 2023-03-03 | SEC |
| 2023-04-05 | S, sale reported on Form 4 | 120,000 | $1.9M | 2023-04-07 | SEC |
| 2023-05-03 | S, sale reported on Form 4 | 120,000 | $1.7M | 2023-05-05 | SEC |
| 2023-05-17 | S, sale reported on Form 4 | 51,552 | $722.2K | 2023-05-18 | SEC |
| 2023-08-17 | S, sale reported on Form 4 | 51,552 | $1.5M | 2023-08-18 | SEC |
| 2023-11-17 | S, sale reported on Form 4 | 200 | $5.9K | 2023-11-20 | SEC |
| 2023-11-17 | S, sale reported on Form 4 | 51,352 | $1.5M | 2023-11-20 | SEC |
| 2024-08-19 | S, sale reported on Form 4 | 16,192 | $394.9K | 2024-08-20 | SEC |
| 2024-08-19 | S, sale reported on Form 4 | 11,197 | $281.4K | 2024-08-20 | SEC |
| 2024-11-19 | S, sale reported on Form 4 | 25,514 | $571.3K | 2024-11-20 | SEC |
| 2024-11-19 | S, sale reported on Form 4 | 1,875 | $42.7K | 2024-11-20 | SEC |
| 2025-01-28 | S, sale reported on Form 4 | 326,932 | $11.9M | 2025-01-30 | SEC |
| 2025-01-29 | S, sale reported on Form 4 | 4,000 | $147.3K | 2025-01-30 | SEC |
| 2025-01-29 | S, sale reported on Form 4 | 269,068 | $9.8M | 2025-01-30 | SEC |
| 2025-02-19 | S, sale reported on Form 4 | 31,467 | $1.1M | 2025-02-19 | SEC |
| 2025-02-19 | S, sale reported on Form 4 | 76 | $2.8K | 2025-02-19 | SEC |
| 2025-02-25 | S, sale reported on Form 4 | 37,101 | $1.3M | 2025-02-27 | SEC |
| 2025-02-25 | S, sale reported on Form 4 | 37,899 | $1.3M | 2025-02-27 | SEC |
| 2025-03-25 | S, sale reported on Form 4 | 75,000 | $2.8M | 2025-03-27 | SEC |
| 2025-04-22 | S, sale reported on Form 4 | 75,000 | $2.6M | 2025-04-24 | SEC |
| 2025-05-19 | S, sale reported on Form 4 | 400 | $13.5K | 2025-05-20 | SEC |
| 2025-05-19 | S, sale reported on Form 4 | 25,756 | $858.2K | 2025-05-20 | SEC |
| 2025-05-20 | S, sale reported on Form 4 | 75,000 | $2.5M | 2025-05-20 | SEC |
| 2025-07-01 | S, sale reported on Form 4 | 1,600 | $68.6K | 2025-07-03 | SEC |
| 2025-07-01 | S, sale reported on Form 4 | 18,300 | $777.8K | 2025-07-03 | SEC |
| 2025-07-01 | S, sale reported on Form 4 | 1,700 | $72.9K | 2025-07-03 | SEC |
| 2025-07-01 | S, sale reported on Form 4 | 18,400 | $782.2K | 2025-07-03 | SEC |
| 2025-07-02 | S, sale reported on Form 4 | 20,000 | $854.6K | 2025-07-03 | SEC |
| 2025-08-07 | S, sale reported on Form 4 | 13,216 | $603.2K | 2025-08-11 | SEC |
| 2025-08-07 | S, sale reported on Form 4 | 6,784 | $305.9K | 2025-08-11 | SEC |
| 2025-08-08 | S, sale reported on Form 4 | 8,205 | $383.3K | 2025-08-11 | SEC |
| 2025-08-08 | S, sale reported on Form 4 | 11,795 | $541.2K | 2025-08-11 | SEC |
| 2025-08-20 | S, sale reported on Form 4 | 428 | $21.1K | 2025-08-22 | SEC |
| 2025-08-20 | S, sale reported on Form 4 | 25,728 | $1.3M | 2025-08-22 | SEC |
| 2025-09-04 | S, sale reported on Form 4 | 14,558 | $744.8K | 2025-09-08 | SEC |
| 2025-09-04 | S, sale reported on Form 4 | 5,442 | $282.2K | 2025-09-08 | SEC |
| 2025-09-04 | S, sale reported on Form 4 | 14,525 | $743.0K | 2025-09-08 | SEC |
| 2025-09-04 | S, sale reported on Form 4 | 5,475 | $283.9K | 2025-09-08 | SEC |
| 2025-09-05 | S, sale reported on Form 4 | 800 | $43.0K | 2025-09-08 | SEC |
| 2025-09-05 | S, sale reported on Form 4 | 2,300 | $119.5K | 2025-09-08 | SEC |
| 2025-09-05 | S, sale reported on Form 4 | 900 | $48.4K | 2025-09-08 | SEC |
| 2025-09-05 | S, sale reported on Form 4 | 16,900 | $898.4K | 2025-09-08 | SEC |
| 2025-09-05 | S, sale reported on Form 4 | 2,300 | $119.5K | 2025-09-08 | SEC |
| 2025-09-05 | S, sale reported on Form 4 | 16,800 | $893.1K | 2025-09-08 | SEC |
| 2025-10-08 | S, sale reported on Form 4 | 8,706 | $473.5K | 2025-10-10 | SEC |
| 2025-10-08 | S, sale reported on Form 4 | 11,295 | $622.2K | 2025-10-10 | SEC |
| 2025-10-08 | S, sale reported on Form 4 | 8,705 | $473.5K | 2025-10-10 | SEC |
| 2025-10-08 | S, sale reported on Form 4 | 11,294 | $622.2K | 2025-10-10 | SEC |
| 2025-10-09 | S, sale reported on Form 4 | 20,000 | $1.1M | 2025-10-10 | SEC |
| 2025-11-06 | S, sale reported on Form 4 | 100 | $6.4K | 2025-11-10 | SEC |
| 2025-11-06 | S, sale reported on Form 4 | 12,529 | $788.2K | 2025-11-10 | SEC |
| 2025-11-06 | S, sale reported on Form 4 | 7,371 | $468.5K | 2025-11-10 | SEC |
| 2025-11-06 | S, sale reported on Form 4 | 12,576 | $791.2K | 2025-11-10 | SEC |
| 2025-11-06 | S, sale reported on Form 4 | 7,324 | $465.4K | 2025-11-10 | SEC |
| 2025-11-07 | S, sale reported on Form 4 | 12,492 | $763.8K | 2025-11-10 | SEC |
| 2025-11-07 | S, sale reported on Form 4 | 7,308 | $452.1K | 2025-11-10 | SEC |
| 2025-11-07 | S, sale reported on Form 4 | 200 | $12.6K | 2025-11-10 | SEC |
| 2025-11-07 | S, sale reported on Form 4 | 12,234 | $747.9K | 2025-11-10 | SEC |
| 2025-11-07 | S, sale reported on Form 4 | 7,546 | $466.9K | 2025-11-10 | SEC |
| 2025-11-07 | S, sale reported on Form 4 | 220 | $13.8K | 2025-11-10 | SEC |
| 2025-11-20 | S, sale reported on Form 4 | 6,401 | $415.9K | 2025-11-24 | SEC |
| 2025-11-20 | S, sale reported on Form 4 | 5,456 | $364.0K | 2025-11-24 | SEC |
| 2025-11-20 | S, sale reported on Form 4 | 14,299 | $942.3K | 2025-11-24 | SEC |
| 2025-12-04 | S, sale reported on Form 4 | 2,100 | $153.6K | 2025-12-08 | SEC |
| 2025-12-04 | S, sale reported on Form 4 | 12,192 | $907.3K | 2025-12-08 | SEC |
| 2025-12-04 | S, sale reported on Form 4 | 5,708 | $427.0K | 2025-12-08 | SEC |
| 2025-12-04 | S, sale reported on Form 4 | 12,200 | $907.9K | 2025-12-08 | SEC |
| 2025-12-04 | S, sale reported on Form 4 | 5,700 | $426.4K | 2025-12-08 | SEC |
| 2025-12-05 | S, sale reported on Form 4 | 12,517 | $914.4K | 2025-12-08 | SEC |
| 2025-12-05 | S, sale reported on Form 4 | 7,712 | $568.8K | 2025-12-08 | SEC |
| 2025-12-05 | S, sale reported on Form 4 | 12,288 | $897.5K | 2025-12-08 | SEC |
| 2025-12-05 | S, sale reported on Form 4 | 7,483 | $551.9K | 2025-12-08 | SEC |
| 2025-12-15 | S, sale reported on Form 4 | 1,700 | $127.9K | 2025-12-16 | SEC |
| 2025-12-15 | S, sale reported on Form 4 | 28,311 | $2.1M | 2025-12-16 | SEC |
| 2026-01-08 | S, sale reported on Form 4 | 11,515 | $848.0K | 2026-01-12 | SEC |
| 2026-01-08 | S, sale reported on Form 4 | 400 | $30.1K | 2026-01-12 | SEC |
| 2026-01-08 | S, sale reported on Form 4 | 8,085 | $601.4K | 2026-01-12 | SEC |
| 2026-01-08 | S, sale reported on Form 4 | 300 | $22.6K | 2026-01-12 | SEC |
| 2026-01-08 | S, sale reported on Form 4 | 11,565 | $851.8K | 2026-01-12 | SEC |
| 2026-01-08 | S, sale reported on Form 4 | 8,135 | $605.1K | 2026-01-12 | SEC |
| 2026-01-09 | S, sale reported on Form 4 | 2,151 | $162.9K | 2026-01-12 | SEC |
| 2026-01-09 | S, sale reported on Form 4 | 1,855 | $144.9K | 2026-01-12 | SEC |
| 2026-01-09 | S, sale reported on Form 4 | 10,677 | $827.0K | 2026-01-12 | SEC |
| 2026-01-09 | S, sale reported on Form 4 | 6,067 | $464.3K | 2026-01-12 | SEC |
| 2026-01-09 | S, sale reported on Form 4 | 1,401 | $105.9K | 2026-01-12 | SEC |
| 2026-01-09 | S, sale reported on Form 4 | 375 | $29.3K | 2026-01-12 | SEC |
| 2026-01-09 | S, sale reported on Form 4 | 10,519 | $816.4K | 2026-01-12 | SEC |
| 2026-01-09 | S, sale reported on Form 4 | 6,955 | $533.6K | 2026-01-12 | SEC |
| 2026-02-10 | S, sale reported on Form 4 | 5,799 | $419.2K | 2026-02-12 | SEC |
| 2026-02-10 | S, sale reported on Form 4 | 14,040 | $1.0M | 2026-02-12 | SEC |
| 2026-02-10 | S, sale reported on Form 4 | 5,960 | $430.7K | 2026-02-12 | SEC |
| 2026-02-10 | S, sale reported on Form 4 | 14,201 | $1.0M | 2026-02-12 | SEC |
| 2026-02-11 | S, sale reported on Form 4 | 7,860 | $555.7K | 2026-02-12 | SEC |
| 2026-02-11 | S, sale reported on Form 4 | 3,994 | $292.6K | 2026-02-12 | SEC |
| 2026-02-11 | S, sale reported on Form 4 | 3,961 | $290.1K | 2026-02-12 | SEC |
Newest 100 of 158
BridgeBio Oncology Therapeutics, Inc. (BBOT)
Director · 1 filing · 0 purchases and sales
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Maze Therapeutics, Inc. (MAZE)
Director · 1 filing · 0 purchases and sales
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Source
Counted from the Form 4 filings this reporting owner (SEC CIK 1742485) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
